Transcriptomics is primarily the study of the complete set of transcripts (RNA molecules) provided by a particular organism. In the present scenario, the transcriptome analysis of varied organisms is facilitated with the aid of technologically advanced platforms. Transcriptomics technologies make use of empirical and theoretical understandings from the pharmaceutical and biotechnology industry to back its healthcare and medical research projects.

1. Transcriptomics Technologies Market - Global
Industry Analysis, Size, Share, Growth,
Trends and Forecast Upto 2019
Transparency Market Research, a global market intelligence
consultancy, has published a market study on the global transcriptomics
technologies market for the 2013-2019 period. According to this report,
the global transcriptomics technologies market will rise at a CAGR of
15.90% from 2013 to 2019 to reach a valuation of US$4.6 bn by the end
of the forecast period. The market’s valuation in 2012 was US$1.65 bn.
The report is titled “Transcriptomics Technologies Market - Global
Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 –
2019”.
Transcriptomics is one of the flourishing “Omics” technologies
(proteomics, genomics, metabolomics and others) across the globe.
Transcriptomics research provides insights on structure and function of
complete set of RNA molecules present in a given cell. Currently, the
analysis of transcriptome of several organisms is facilitated with the help
of advanced technological platforms such as next generation sequencing
platforms followed by polymerase chain reaction, microarrays and gene
regulation technologies.
These technologies are applied in the process of drug discovery, medical
research, clinical diagnosis of diseases and others. With the burgeoning
demand for targeted therapeutics and continuous improvements in
healthcare infrastructure, transcriptomics technologies promise lucrative

2. commercialization prospects. Hence, transcriptomics research enables
development of potential and novel therapeutics and diagnostics.
Evolution of technological analysis platforms such as next generation
sequencing technologies, microRNA technology, RNA interference
technology and PCR technologies enable effective analysis of
transcriptome of different organisms with greater precision and accuracy.
Currently, there is a demand for technology sophistication to ensure
optimum results.
For example, presently, there is a need for multiplexed RNA sequencing
and quantagene RT-PCR which enable the sequencing and analysis of
numerous transcripts and reads simultaneously. These technological
sophistications in turn create a demand for effective data analysis tools
and service (bioinformatics) in order to handle and manage huge amount
of data from these technological platforms.
Browse Full Research Report on Transcriptomics Technologies
Market:
http://www.transparencymarketresearch.com/transcriptomics-
technologies-market.html
Transcriptomics technologies are applied majorly in studying gene
expression patterns, drug discovery and clinical diagnosis of disorders
such as cardiovascular, central nervous system disorders, cancers and
others. Transcriptome analysis tools and services are used in
identification of novel gene sequences and potential drug targets. Also,
they provide insights about gene expression patterns and gene regulation
mechanisms that are responsible to trigger the functioning and
production of proteins.
There is a lot of complexity involved in study of structural and
functional aspects of complete set of transcripts present in a given cell or
population of cells. Henceforth, several pharmaceutical and

3. biotechnology companies are investing in medical research to develop
robust methodologies with high efficiency and reliability.
Geographically, North America dominated the global transcriptomics
technologies market in 2012 with a revenue share of over 35%. Presence
of well equipped medical and research laboratories, increased awareness
of biotechnological research and increased participation of respective
governments are some of the major factors responsible for region’s
leadership position. Factors such as continuous improvisation in
healthcare infrastructure, rigorous research and development initiatives
followed by increased commercialization of research outcomes are
expected to drive the growth of this market during the forecast period.
In Asia-Pacific region ongoing development of technologies and
infrastructure facilities along with increasing acceptance towards the
novel approaches in biotechnology research will further enhance the
uptake of transcriptomics technologies and drive market growth.
On the other hand factors which might hamper the growth of overall
transcriptomics market are lack of effective computational biology tools
and services required for efficient analysis of complex data followed by
lack of domain expertise.
Browse Full Press Release on Transcriptomics Technologies Market:
About Us
Transparency Market Research (TMR) is a global market intelligence
company providing business information reports and services. The
company’s exclusive blend of quantitative forecasting and trend analysis
provides forward-looking insight for thousands of decision makers.
Press Release

4. TMR’s experienced team of analysts, researchers, and consultants use
proprietary data sources and various tools and techniques to gather and
analyze information.
TMR’s data repository is continuously updated and revised by a team of
research experts so that it always reflects the latest trends and
information. With extensive research and analysis capabilities,
Transparency Market Research employs rigorous primary and secondary
research techniques to develop distinctive data sets and research material
for business reports.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com